Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Tyrer PC"'
Autor:
Zammarchi F; ADC Therapeutics (UK) Limited, London, United Kingdom., Corbett S; Spirogen/Medimmune Ltd, London, United Kingdom; and.; Cancer Research UK Drug DNA Interactions Research Group and., Adams L; Spirogen/Medimmune Ltd, London, United Kingdom; and., Tyrer PC; Spirogen/Medimmune Ltd, London, United Kingdom; and., Kiakos K; Cancer Research UK Drug DNA Interactions Research Group and., Janghra N; Department of Pathology, University College London Cancer Institute, London, United Kingdom., Marafioti T; Department of Pathology, University College London Cancer Institute, London, United Kingdom., Britten CE; ADC Therapeutics (UK) Limited, London, United Kingdom., Havenith CEG; ADC Therapeutics (UK) Limited, London, United Kingdom., Chivers S; ADC Therapeutics (UK) Limited, London, United Kingdom., D'Hooge F; Spirogen/Medimmune Ltd, London, United Kingdom; and., Williams DG; Spirogen/Medimmune Ltd, London, United Kingdom; and., Tiberghien A; Spirogen/Medimmune Ltd, London, United Kingdom; and., Howard PW; Spirogen/Medimmune Ltd, London, United Kingdom; and., Hartley JA; ADC Therapeutics (UK) Limited, London, United Kingdom.; Spirogen/Medimmune Ltd, London, United Kingdom; and.; Cancer Research UK Drug DNA Interactions Research Group and., van Berkel PH; ADC Therapeutics (UK) Limited, London, United Kingdom.
Publikováno v:
Blood [Blood] 2018 Mar 08; Vol. 131 (10), pp. 1094-1105. Date of Electronic Publication: 2018 Jan 03.
Autor:
Flynn MJ; Cancer Research UK Drug DNA Interactions Research Group, UCL Cancer Institute, London, United Kingdom.; Spirogen Ltd, QMB Innovation Centre, London, United Kingdom., Zammarchi F; ADC Therapeutics (UK) Limited, QMB Innovation Centre, London, United Kingdom., Tyrer PC; Spirogen Ltd, QMB Innovation Centre, London, United Kingdom., Akarca AU; Department of Pathology, University College London, London, United Kingdom., Janghra N; Department of Pathology, University College London, London, United Kingdom., Britten CE; ADC Therapeutics (UK) Limited, QMB Innovation Centre, London, United Kingdom., Havenith CE; ADC Therapeutics (UK) Limited, QMB Innovation Centre, London, United Kingdom., Levy JN; Spirogen Ltd, QMB Innovation Centre, London, United Kingdom., Tiberghien A; Spirogen Ltd, QMB Innovation Centre, London, United Kingdom., Masterson LA; Spirogen Ltd, QMB Innovation Centre, London, United Kingdom., Barry C; Spirogen Ltd, QMB Innovation Centre, London, United Kingdom., D'Hooge F; Spirogen Ltd, QMB Innovation Centre, London, United Kingdom., Marafioti T; Department of Pathology, University College London, London, United Kingdom., Parren PW; Genmab, Utrecht, the Netherlands.; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, the Netherlands., Williams DG; Spirogen Ltd, QMB Innovation Centre, London, United Kingdom., Howard PW; Spirogen Ltd, QMB Innovation Centre, London, United Kingdom., van Berkel PH; ADC Therapeutics (UK) Limited, QMB Innovation Centre, London, United Kingdom., Hartley JA; Cancer Research UK Drug DNA Interactions Research Group, UCL Cancer Institute, London, United Kingdom. john.hartley@ucl.ac.uk.; Spirogen Ltd, QMB Innovation Centre, London, United Kingdom.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2016 Nov; Vol. 15 (11), pp. 2709-2721. Date of Electronic Publication: 2016 Aug 17.
Autor:
Keenan JI; Department of Surgery, University of Otago, Christchurch, New Zealand., Hooper EM; Department of Paediatrics, University of Otago, Christchurch, New Zealand., Tyrer PC; Department of Surgery, University of Otago, Christchurch, New Zealand., Day AS; Department of Paediatrics, University of Otago, Christchurch, New Zealand andrew.day@otago.ac.nz.
Publikováno v:
Innate immunity [Innate Immun] 2014 Nov; Vol. 20 (8), pp. 848-56. Date of Electronic Publication: 2013 Dec 10.
Autor:
Tyrer PC; Department of Surgery, University of Otago Christchurch, PO Box 4345, Christchurch 8140, New Zealand. peter.tyrer@otago.ac.nz., Frizelle FA, Keenan JI
Publikováno v:
Infectious agents and cancer [Infect Agent Cancer] 2014 Jan 10; Vol. 9 (1), pp. 2. Date of Electronic Publication: 2014 Jan 10.
Autor:
Coray DS; School of Biological Sciences, University of Canterbury, Private Bag 4800, Christchurch, New Zealand., Heinemann JA, Tyrer PC, Keenan JI
Publikováno v:
World journal of microbiology & biotechnology [World J Microbiol Biotechnol] 2012 May; Vol. 28 (5), pp. 1871-80. Date of Electronic Publication: 2012 Feb 07.
Autor:
Tyrer PC; Inflammatory Bowel Disease Research Group, Level 5, Building 10, The Canberra Hospital, Yamba Drive, Garran, ACT 2606, Australia. peter.tyrer@otago.ac.nz, Bean EG, Ruth Foxwell A, Pavli P
Publikováno v:
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2011 Sep 23; Vol. 413 (2), pp. 336-41. Date of Electronic Publication: 2011 Aug 27.
Autor:
Tyrer PC; Macrophage Research Group, The Canberra Hospital, Canberra, ACT, Australia., Ruth Foxwell A, Kyd JM, Otczyk DC, Cripps AW
Publikováno v:
Vaccine [Vaccine] 2007 Apr 20; Vol. 25 (16), pp. 3204-9. Date of Electronic Publication: 2007 Jan 17.